Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Changes in the Immune Responses With Reduxium in Healthy Adults

NCT04525456 is registered in ClinicalTrials.gov with Ogevity Therapeutics, Inc. as lead sponsor.

NCT NCT04525456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04525456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Changes in the Immune Responses With Reduxium in Healthy Adults
Lead sponsor
Ogevity Therapeutics, Inc.
Phase
Not applicable
Overall status
Completed
Start date
October 7, 2020
Completion date
January 27, 2021
Enrollment
20 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

immune tolerance, viral infection